» Articles » PMID: 35028819

Nuclear Cardiac Imaging in the Interventional Suite

Overview
Publisher Current Science
Date 2022 Jan 14
PMID 35028819
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This review presents the current state of imaging approaches that enable real-time molecular imaging in the interventional suite and discusses the potential future use of integrated nuclear imaging and fluoroscopy for intraprocedural guidance in the evaluation and treatment of both cardiovascular and oncological diseases.

Recent Findings: Although there are no commercially available real-time hybrid nuclear imaging devices that are approved for use in the interventional suite, prototype open gantry hybrid nuclear imaging and x-ray c-arm imaging systems and theranostic catheter for location radiotracer detection are currently undergoing development and testing by multiple groups. The integration of physiological and molecular targeted nuclear imaging for real-time delivery of targeted theranostics in the interventional laboratory may enable more personalized care for a wide variety of cardiovascular procedures and improve patient outcomes.

References
1.
Gyongyosi M, Dib N . Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease. Nat Rev Cardiol. 2011; 8(7):393-404. DOI: 10.1038/nrcardio.2011.64. View

2.
Dietze M, Kunnen B, Lam M, W A M de Jong H . Interventional respiratory motion compensation by simultaneous fluoroscopic and nuclear imaging: a phantom study. Phys Med Biol. 2021; 66(6):065001. DOI: 10.1088/1361-6560/abe556. View

3.
Chan C, Liu H, Grobshtein Y, Stacy M, Sinusas A, Liu C . Noise suppressed partial volume correction for cardiac SPECT/CT. Med Phys. 2016; 43(9):5225. PMC: 5001975. DOI: 10.1118/1.4961391. View

4.
Lang T, Hasegawa B, Liew S, Brown J, Blankespoor S, Reilly S . Description of a prototype emission-transmission computed tomography imaging system. J Nucl Med. 1992; 33(10):1881-7. View

5.
Li J, Hu S, Zhu D, Huang K, Mei X, Lopez de Juan Abad B . All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart. J Am Heart Assoc. 2021; 10(8):e020402. PMC: 8174178. DOI: 10.1161/JAHA.120.020402. View